Adiposs raises CHF 1.8m in first closing of pre-Series A equity round
Adiposs, the developer of a unique diagnostic product for the non-invasive early detection of body wasting-cachexia, raises CHF 1.8 million in first closing of its Pre-Series A equity round.
The round was led by Privilège Ventured, a Swiss-based venture capital focused on seed and early-stage investments. Other investors include CR Ventures, Kick Foundation, Fondation Genevoise pour l’Innovation Technologique (Fongit), s Singapore-based family office (Kingbridge) and a group of business angels.
The investment round will be used to manufacture the first batch of ImageBAT, a first-in-class contrast agent brown adipose tissue detection, as well as to perform the first-in-human clinical trial.
Id est avocats acted as legal counsel.
